Accelerated Enrollment Solutions (AES)

Orlando, Florida 32806

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Chronic Gout, Mild to Moderate Alzheimer's Disease

Studies at this site

• A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
• A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy — Completed
• Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease — Completed